Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study. [electronic resource]
- Neuropsychiatric disease and treatment Apr 2010
- 71-9 p. digital